
Professor Beverley Hunt OBE (also on BlueSky)
@bhwords
Passionate about thrombosis & bleeding care. Founder of Thrombosis UK but views are my own. Crazed cyclist.
ID: 753567488
12-08-2012 18:32:24
5,5K Tweet
10,10K Followers
2,2K Following



Today, we have launched MaTRON, our UK-wide project looking at management of intermediate and high risk PE in pregnancy. This data is desperately needed to help plan services and future studies. There's still time to get involved tinyurl.com/22b3ucwp Giulia Simini Professor Beverley Hunt OBE (also on BlueSky)





Presentations from #LTC24 now available. With tragic cases of missed diagnosis hitting the headlines, Professor Beverley Hunt OBE (also on BlueSky) discusses evidence & aids to raising early suspicion & diagnosis of #bloodclots 'Diagnosing DVT clinically – just as hard as ever!' youtu.be/9qDM6PIg1LE?si… via YouTube


Everything you need to know about blood clots – following Mrs Hinch’s treatment weeks after giving birth Thanks to Mrs Hitch & The Independent for running this & increasing awareness of clots - now the no cause of death in pregnancy independent.co.uk/life-style/hea…


👇🏼👇🏼👇🏼 without the support of my HSANZ clinical fellowship grant my time at Guy's and St Thomas' with Professor Beverley Hunt OBE (also on BlueSky) wouldn’t have been possible! Forever grateful for their support. 🙏🏻 Can strongly recommend to others!

We learnt a lot about how difficult it is to organise VTE risk assesssment at a national level & discussed the current areas of controversy- it’s all on line Thrombosis UK worth a look!

Professor Beverley Hunt OBE (also on BlueSky) kicking off #BMFMS2025 with VTE in pregnancy Caroline Ovadia Etienne Ciantar RoyalCollegeObsGyn BMFMS




09:30 BST - #NTW25: Join Professor Beverley Hunt OBE (also on BlueSky) discussing 'Improving VTE prevention in pregnancy & the puerperium' with presentations shared at yesterday's @ tuk-edu.vfairs.com


We want to learn from you! How do you evaluate heavy menstrual bleeding in patients on anticoagulation. Take our survey: redcap.link/f8v5m0si CardioNerds ISTH ASH PERT Consortium World Thrombosis Day Shematologist, MD Professor Beverley Hunt OBE (also on BlueSky) Alisa Wolberg @fnainle

Is this the end of rivaroxaban for acute VTE? Lana Castellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025


The best thing about #ISTH2025 is catching up with old friends and colleagues. Professor Beverley Hunt OBE (also on BlueSky) Andrew Doyle


Antithrombin has multiple effects haemostatically but is it involved in inflammatory pathways? Find out in this paper from Professor Beverley Hunt OBE (also on BlueSky) Kasia Mayger & Rui Leite kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…